Reduction of Carrageenan- Bradykinin- and Histamine-induced Acute Inflammation by Experimental Eosinophilia in Rats

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 1982 Jul 1

PMID 7095830

Citations 2

Authors

H Popper

O Picher

H Auer

Affiliations

Soon will be listed here.

Abstract

An examination was made of the effects of eosinophilia on acute inflammation. Sprague Dawley rats were infected with Trichinella spiralis larvae which resulted in a blood eosinophilia. Groups of rats with the induced eosinophilia, and untreated rats without the eosinophilia, were treated with carrageenan, bradykinin or histamine in the hind paw to induce local inflammation. Paw oedema induced by carrageenan as a measure of the inflammation was much reduced in those rats with an eosinophilia, and slightly but significantly reduced in the site treated with histamine or bradykinin. Though other anti-inflammatory factors may have participated, it is believed that the reduction in inflammation was due to the eosinophils. Pretreatment of the rat paws with an eosinophil chemotactic factor tetrapeptide (ECF-A) caused no chemotaxis and therefore no effect on histamine-induced oedema.

Citing Articles

Experimental monoarthritis. Modulatory effect of injected eosinophils on influx of various types of inflammatory cells.

Popper H Inflammation. 1984; 8(3):301-12.

PMID: 6490138 DOI: 10.1007/BF00916418.

Activation and release of enzymes and major basic protein from guinea pig eosinophil granulocytes induced by different inflammatory stimuli and other substances. A histochemical, biochemical, and electron microscopic study.

Popper H, Knipping G, Czarnetzki B, Steiner R, Helleis G, Auer H Inflammation. 1989; 13(2):147-62.

PMID: 2759682 DOI: 10.1007/BF00924786.

References

Beeson P . Immunology of the gut: role of the eosinophil. Ciba Found Symp. 1977; (46):203-23. DOI: 10.1002/9780470720288.ch10. View

Kay A . Studies on eosinophil leucocyte migration. I. Eosinophil and neutrophil accumulation following antigen-antibody reactions in guinea-pig skin. Clin Exp Immunol. 1970; 6(1):75-86. PMC: 1712766. View

Lembeck F, Popper H, Juan H . Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic effect. Naunyn Schmiedebergs Arch Pharmacol. 1976; 294(1):69-73. DOI: 10.1007/BF00692786. View

Wedmore C, Williams T . Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981; 289(5799):646-50. DOI: 10.1038/289646a0. View

Konig W, Czarnetzki B, Lichtenstein L . Generation and release of eosinophil chemotactic factor from human polymorphonuclear leukocytes. Monogr Allergy. 1977; 12:198-212. View

Clark R, Sandler J, Gallin J, Kaplan A . Histamine modulation of eosinophil migration. J Immunol. 1977; 118(1):137-45. View

Kater L, Goetzl E, Austen K . Isolation of human eosinophil phospholipase D. J Clin Invest. 1976; 57(5):1173-80. PMC: 436770. DOI: 10.1172/JCI108385. View

Wasserman S, Goetzl E, Austen K . Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. J Immunol. 1975; 114(2 Pt 1):645-9. View

Di Rosa M, Giroud J, Willoughby D . Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol. 1971; 104(1):15-29. DOI: 10.1002/path.1711040103. View

10.

Gzarnetzki B, Konig W, Lichtenstein L . Release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by calcium ionophore A23187 and phagocytosis. Nature. 1975; 258(5537):725-6. DOI: 10.1038/258725a0. View

11.

Bass D, Gonwa T, Szejda P, Cousart M, Dechatelet L, McCall C . Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest. 1980; 65(6):1265-71. PMC: 371463. DOI: 10.1172/JCI109789. View

12.

ARCHER R, FELDBERG W, KOVACS B . Antihistamine activity in extracts of horse eosinophils. Br J Pharmacol Chemother. 1962; 18:101-8. PMC: 1482173. DOI: 10.1111/j.1476-5381.1962.tb01154.x. View

13.

Bass D . Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest. 1975; 56(4):870-9. PMC: 301942. DOI: 10.1172/JCI108166. View

14.

Berenberg J, Ward P . Chemotactic factor inactivator in normal human serum. J Clin Invest. 1973; 52(5):1200-6. PMC: 302376. DOI: 10.1172/jci107287. View

15.

Goetzl E, Wasserman S, Austen F . Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity. Arch Pathol. 1975; 99(1):1-4. View

16.

Kay A . Eosinophil leucocytes: recruitment, localization and function in immediate-type hypersensitivity. Monogr Allergy. 1977; 12:222-30. View

17.

Parish W . Substances that attract eosinophils in vitro and in vivo, and that elicit blood eosinophilia. Antibiot Chemother (1971). 1974; 19:233-70. DOI: 10.1159/000395434. View

18.

Hubscher T . Role of the eosinophil in the allergic reactions. I. EDI-an eosinophil-derived inhibitor of histamine release. J Immunol. 1975; 114(4):1379-88. View

19.

Geotzl E, Austen K . Eosinophil chemotactic factor of anaphylaxis (ECF-A): cellular origin, structure and function. Monogr Allergy. 1977; 12:189-97. View

20.

Kazura J, Grove D . Stage-specific antibody-dependent eosinophil-mediated destruction of Trichinella spiralis. Nature. 1978; 274(5671):588-9. DOI: 10.1038/274588a0. View